ValuEngine Downgrades Aethlon Medical, Inc. (AEMD) to Strong Sell
Aethlon Medical, Inc. (OTCMKTS:AEMD) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday.
Shares of Aethlon Medical (AEMD) opened at 0.971 on Wednesday. The company’s 50 day moving average price is $1.56 and its 200 day moving average price is $1.98. Aethlon Medical has a one year low of $0.90 and a one year high of $5.18. The stock’s market capitalization is $8.64 million.
Aethlon Medical (OTCMKTS:AEMD) last released its quarterly earnings results on Thursday, August 10th. The medical equipment provider reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.05). On average, equities analysts expect that Aethlon Medical will post ($0.50) earnings per share for the current year.
Aethlon Medical Company Profile
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Stock Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related stocks with our FREE daily email newsletter.